Medical and Scientific Advisory Board
  • Keith Hyland, PhD
    Director of Neurochemistry Laboratory
    Kimberly H. Courtwright & Joseph W. Summers Institute of Metabolic Disease
    Baylor University Medical Center
    Dallas, Texas

     

  • Darryl C. De Vivo, MD
    Sidney Carter Professor of Neurology
    Professor of Pediatrics
    Director of Pediatric Neurology
    New York Presbyterian Hospital
    Columbia Presbyterian Hospital
    New York, New York

  • K. Michael Gibson, PhD, FACMG
    Professor
    Molecular and Medical Genetics & Pediatrics
    Director, Biochemical Genetics Laboratory
    Oregon Health Sciences University
    Portland, Oregon
  • Kathryn J. Swoboda, MD
    Pediatric Neurology and Genetics
    Primary Children's Medical Center
    Salt Lake City, Utah
  • Phillip L. Pearl, MD
    Associate Professor of Pediatrics and Neurology
    The George Washington University School of Medicine
    Children's National Medical Center
    Washington, DC
  • Andrea Gropman, MD
    Pediatric Neurology and Genetics
    National Institute of Health and Children's National Medical Center
    Neurogenetics Branch
    Bethesda, Maryland
  • Clive N. Svendsen Ph.D.
    Coordinator, Pathology, Histology, Stereology
    Waisman Center
    Madison Wisconsin

  • Nenad Blau, PhD
    Division of Clinical Chemistry & Biochemistry
    University of Children's Hospital
    Zurich, Switzerland

 

  • Georg F. Hoffmann, MD
    Department of Pediatrics
    University of Heidelberg
    Heidelberg, Germany
  • Masaya Segawa MD, PhD
    Segawa Neurological Clinic
    Tokyo ,Japan
  • Roser Pons, MD
    Movement Disorder Center
    Columbia Presbyterian Medical Center
    New York, New York
  • Blair Ford, MD
    Movement Disorder Center
    Columbia Presbyterian Medical Center
    New York, New York

2003 Pediatric Neurotransmitter Disease Association

www.pndassoc.org